陈辉, 张建军, 侯燕. 莫西沙星雾化吸入辅治高龄慢性支气管炎急性发作的临床观察及护理[J]. 实用临床医药杂志, 2017, (14): 34-36. DOI: 10.7619/jcmp.201714010
引用本文: 陈辉, 张建军, 侯燕. 莫西沙星雾化吸入辅治高龄慢性支气管炎急性发作的临床观察及护理[J]. 实用临床医药杂志, 2017, (14): 34-36. DOI: 10.7619/jcmp.201714010
CHEN Hui, ZHANG Jianjun, HOU Yan. Clinical observation and nursing of Moxifloxacin in adjuvant treatment of elderly patients with chronic bronchitis in acute attack period[J]. Journal of Clinical Medicine in Practice, 2017, (14): 34-36. DOI: 10.7619/jcmp.201714010
Citation: CHEN Hui, ZHANG Jianjun, HOU Yan. Clinical observation and nursing of Moxifloxacin in adjuvant treatment of elderly patients with chronic bronchitis in acute attack period[J]. Journal of Clinical Medicine in Practice, 2017, (14): 34-36. DOI: 10.7619/jcmp.201714010

莫西沙星雾化吸入辅治高龄慢性支气管炎急性发作的临床观察及护理

Clinical observation and nursing of Moxifloxacin in adjuvant treatment of elderly patients with chronic bronchitis in acute attack period

  • 摘要: 目的 探讨高龄慢性支气管炎急性发作应用莫西沙星雾化吸入辅治的效果以及治疗期间的护理措施.方法 选择高龄慢性支气管炎急性发作患者124例,随机分为对照组与观察组各62例,对照组给予沙丁胺醇联合左氧氟沙星治疗,实施常规护理,观察组给予莫西沙星联合盐酸氨溴索雾化吸入治疗,实施全面护理干预,观察2组治疗效果、主要症状消除时间及治疗前后患者肺功能.结果 治疗前, 2组患者肺功能指标差异无统计学意义(P>0.05);治疗后,观察组临床疗效、肺功能指标优于对照组,主要症状消除时间短于对照组,差异均有统计学意义(P<0.05).结论 高龄慢性支气管炎急性发作患者采用莫西沙星雾化吸入辅治并给予科学系统的护理干预,可提升治疗效果,缩短治疗时间,提升患者生活质量.

     

/

返回文章
返回